Skip to main content

Advertisement

SpringerLink
Log in

Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

In this study expression of claudins 1, 3, 4 and 5 were studied in 118 cases of gastric carcinoma and compared with proliferation, apoptosis and E-cadherin expression. Expression of all these claudins could be seen in gastric carcinoma, most prominently for claudin 4, and least expression was found for claudin 5. All claudins showed significantly more expression in gastric carcinomas of intestinal type. Their expression was significantly associated with each other. Expression of claudins 4 and 5 was associated with E-cadherin. Strong expression of claudin 5 was associated with higher cell proliferation and apoptosis. Claudin 3 expression had an association with a better prognosis of the patients, especially in the intestinal type. The results show that expression of claudins 1, 3, 4 and 5 is lower in diffuse-type gastric carcinomas. Possibly they play a role in determining the diffuse phenotype and loose cohesion of cells in diffuse type of gastric carcinoma in a similar manner as E-cadherin. The loss of their expression does not clearly associate with poorer prognosis of the patients, except for claudin 3, where strong expression was associated with a better outcome of the patients, a feature especially related to intestinal-type tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Folpe AL, Billings SD, McKenney JK, Walsh SV, Nusrat A, Weiss SW (2002) Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am J Surg Pathol 26:1620–1626

    Article  PubMed  Google Scholar 

  2. Gumbiner B, Stevenson B, Grimaldi A (1988) The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107:1575–1587

    Article  PubMed  CAS  Google Scholar 

  3. Hamilton SR, Aaltonen LA (2000) Tumours of the digestive system. Pathology and genetics. World Health Organization classification of tumours. IARC Press, Lyon, France

    Google Scholar 

  4. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ (2000) Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60:6281–6287

    PubMed  CAS  Google Scholar 

  5. Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y, Tsukita S (2002) Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 13:875–886

    PubMed  CAS  Google Scholar 

  6. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S (2003) Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22:2021–2033

    Article  PubMed  CAS  Google Scholar 

  7. Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S (2004) Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 164:1627–1633

    PubMed  CAS  Google Scholar 

  8. Lauren T (1965) The two histological main types of gastric carcinoma. Acta Pathol Microbiol Scand 64:34

    Google Scholar 

  9. Long H, Crean CD, Lee W-H, Cummings OW, Gabig TG (2001) Expression of clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61:7878–7881

    PubMed  CAS  Google Scholar 

  10. Machado JC, Carneiro F, Beck S, Rossi S, Lopes J, Taveira GA (1998) E-cadherin expression is correlated with the isolated cell/diffuse histotype and with the features of biological aggressiveness of gastric carcinoma. Int J Surg Pathol 6:135–144

    Article  CAS  Google Scholar 

  11. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I (1993) E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53:1690–1695

    PubMed  CAS  Google Scholar 

  12. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, Leder G, Iwamura T, Adler G, Gress TM (2003) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63:6265–6271

    PubMed  CAS  Google Scholar 

  13. Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM (2001) Claudin 4: a new target for pancreatic cancer treatment using clostridium perfringens enterotoxin. Gastroenterology 121:678–684

    Article  PubMed  CAS  Google Scholar 

  14. Mitic LL, van Itallie CM, Anderson JM (2000) Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lesions from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 279:G250–G254

    PubMed  CAS  Google Scholar 

  15. Rahner C, Mitic LL, Anderson JM (2001) Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120:411–422

    Article  PubMed  CAS  Google Scholar 

  16. Reyes JL, Lamas M, Martin D, del Carmen Namorado M, Islas S, Luna J, Tauc M, Gonzalez-Mariscal L (2002) The renal segmental distribution of claudins changes with development. Kidney Int 62:476–487

    Article  PubMed  CAS  Google Scholar 

  17. Sanford JL, Edwards JD, Mays TA, Gong B, Merriam AP, Rafael-Fortney JA (2005) Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice. J Mol Cell Cardiol 38:323–332

    Article  PubMed  CAS  Google Scholar 

  18. Sobin LH, Wittekind CH (2002) TNM classification of malignant tumours. International Union Against Cancer (UICC), 6th edn. Wiley-Liss, New York

    Google Scholar 

  19. Soini Y (2004) Claudins 2, 3, 4 and 5 in Paget's disease and breast carcinoma. Hum Pathol 35:1531–1536

    Article  PubMed  CAS  Google Scholar 

  20. Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A, Lemoine NR (2002) Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 160:1745–1754

    PubMed  CAS  Google Scholar 

  21. Tokes AM, Kulka J, Paku S, Szik A, Paska C, Novak PK, Szilak L, Kiss A, Bögl K, Schaff Z (2005) Claudin 1, 3, and 4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R295–R305

    Article  Google Scholar 

  22. Tsukita S, Furuse M (2000) Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149:13–16

    Article  PubMed  CAS  Google Scholar 

  23. Tsukita S, Furuse M (2002) Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 14:531–536

    Article  PubMed  CAS  Google Scholar 

  24. Turksen K, Troy T-C (2004) Barriers built on claudins. J Cell Sci 117:2435–2447

    Article  PubMed  CAS  Google Scholar 

  25. Wheelock MJ, Jensen PJ (1992) Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol 117:415–425

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The skillful technical assistance of Mrs. Eija Tomperi and Mirja Vahera is greatly appreciated.

Author information

Authors and Affiliations

  1. Department of Pathology, University Hospital of Oulu and Oulu University, P.O. Box 5000, (Aapistie 5), 90014, Oulu, Finland

    Y. Soini

  2. Department of Pathology, Tampere University Hospital, P.O. Box 2000, 33521, Tampere, Finland

    S. Tommola & P. Martikainen

  3. HUSLAB, Division of Pathology, Helsinki University Central Hospital, P.O. Box 400, 00029 HUS, Helsinki, Finland

    H. Helin

Authors
  1. Y. Soini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Tommola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Helin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Martikainen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Soini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soini, Y., Tommola, S., Helin, H. et al. Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch 448, 52–58 (2006). https://doi.org/10.1007/s00428-005-0011-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-005-0011-6

Keywords

Search

Navigation